Literature DB >> 20139697

Role of cell cycle regulators in lung carcinogenesis.

Beatrice Eymin1, Sylvie Gazzeri.   

Abstract

Cellular division is an ordered, tightly regulated process involving multiple checkpoints that assess extracellular growth signals, cell size and DNA integrity. Progression throughout the cell cycle is based on the activation of different CDK-cyclin complexes that prevent cells from entering into a new phase until thay have successfully complete the previous one. In addition, a series of cell cycle checkpoints are designed to preserve genome integrity and chromosomal stability. Neoplastic lung cells develop the ability to bypass several of these checkpoints, and tumor cell proliferation is frequently associated with genetic or epigenetic alterations in key regulators of the cell cycle. The goal of this review is to summarize the knowledge about the dysregulation of major cell cycle regulators in lung cancer pathogenesis and to discuss the use of these proteins as targets for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20139697      PMCID: PMC2852568          DOI: 10.4161/cam.4.1.10977

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  120 in total

Review 1.  Polo-like kinases and the orchestration of cell division.

Authors:  Francis A Barr; Herman H W Silljé; Erich A Nigg
Journal:  Nat Rev Mol Cell Biol       Date:  2004-06       Impact factor: 94.444

Review 2.  Checkpoints: controls that ensure the order of cell cycle events.

Authors:  L H Hartwell; T A Weinert
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

3.  Multiple genetic alterations in small-cell lung carcinoma.

Authors:  J Yokota; N Mori; T Akiyama; Y Shimosato; T Sugimura; M Terada
Journal:  Princess Takamatsu Symp       Date:  1989

4.  Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas.

Authors:  Takaya Kobatake; Masaaki Yano; Shinichi Toyooka; Kazunori Tsukuda; Hideaki Dote; Takefumi Kikuchi; Minoru Toyota; Mamoru Ouchida; Motoi Aoe; Hiroshi Date; Harvey I Pass; Hiroyoshi Doihara; Nobuyoshi Shimizu
Journal:  Oncol Rep       Date:  2004-11       Impact factor: 3.906

5.  Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group.

Authors:  P T Reissmann; H Koga; R Takahashi; R A Figlin; E C Holmes; S Piantadosi; C Cordon-Cardo; D J Slamon
Journal:  Oncogene       Date:  1993-07       Impact factor: 9.867

6.  Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma.

Authors:  Osamu Furonaka; Yukio Takeshima; Hirokazu Awaya; Hajime Ishida; Nobuoki Kohno; Kouki Inai
Journal:  Pathol Int       Date:  2004-08       Impact factor: 2.534

7.  Overexpression of the replication licensing regulators hCdt1 and hCdc6 characterizes a subset of non-small-cell lung carcinomas: synergistic effect with mutant p53 on tumor growth and chromosomal instability--evidence of E2F-1 transcriptional control over hCdt1.

Authors:  Panagiotis Karakaidos; Stavros Taraviras; Leandros V Vassiliou; Panayotis Zacharatos; Nikolaos G Kastrinakis; Dionysia Kougiou; Mirsini Kouloukoussa; Hideo Nishitani; Athanasios G Papavassiliou; Zoi Lygerou; Vassilis G Gorgoulis
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

8.  Overexpression of E2F1 associated with LOH at RB locus and hyperphosphorylation of RB in non-small cell lung carcinoma.

Authors:  Miwa Akasofu Imai; Yoshio Oda; Makoto Oda; Isao Nakanishi; Ei Kawahara
Journal:  J Cancer Res Clin Oncol       Date:  2004-03-03       Impact factor: 4.553

9.  Abnormalities in structure and expression of the human retinoblastoma gene in SCLC.

Authors:  J W Harbour; S L Lai; J Whang-Peng; A F Gazdar; J D Minna; F J Kaye
Journal:  Science       Date:  1988-07-15       Impact factor: 47.728

10.  CHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer.

Authors:  Peilin Zhang; Jie Wang; Weiyi Gao; Bao-Zhu Yuan; John Rogers; Eddie Reed
Journal:  Mol Cancer       Date:  2004-05-04       Impact factor: 27.401

View more
  30 in total

1.  Combination therapy induces unfolded protein response and cytoskeletal rearrangement leading to mitochondrial apoptosis in prostate cancer.

Authors:  Sandeep Kumar; Ajay K Chaudhary; Rahul Kumar; Jordan O'Malley; Anna Dubrovska; Xinjiang Wang; Neelu Yadav; David W Goodrich; Dhyan Chandra
Journal:  Mol Oncol       Date:  2016-03-31       Impact factor: 6.603

2.  Mdig, a lung cancer-associated gene, regulates cell cycle progression through p27(KIP1).

Authors:  Dan Ma; Dan Guo; Wei Li; Hongwen Zhao
Journal:  Tumour Biol       Date:  2015-04-09

3.  AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancer.

Authors:  Ahmed S K Al-Khafaji; Michael W Marcus; Michael P A Davies; Janet M Risk; Richard J Shaw; John K Field; Triantafillos Liloglou
Journal:  Oncol Lett       Date:  2017-04-07       Impact factor: 2.967

4.  Genome-wide analysis of genetic predisposition to common polygenic cancers.

Authors:  Alireza Nazarian; Konstantin G Arbeev; Arseniy P Yashkin; Alexander M Kulminski
Journal:  J Appl Genet       Date:  2022-01-03       Impact factor: 3.240

5.  Antiproliferative Activity of a New Quinazolin-4(3H)-One Derivative via Targeting Aurora Kinase A in Non-Small Cell Lung Cancer.

Authors:  Ji Yun Lee; Huarong Yang; Donghwa Kim; Kay Zin Kyaw; Ruoci Hu; Yanhua Fan; Sang Kook Lee
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-02

6.  Local injection of lentivirus-delivered livinshRNA suppresses lung adenocarcinoma growth by inducing a G0/G1 phase cell cycle arrest.

Authors:  Yu-Sheng Chen; Hong-Ru Li; Yan Miao; Wen-Ying Chen; You-Tang Li; Gui-Qing Wang; Zheng-Cai Wu
Journal:  Int J Clin Exp Pathol       Date:  2012-10-01

7.  Gigantol Targets MYC for Ubiquitin-proteasomal Degradation and Suppresses Lung Cancer Cell Growth.

Authors:  Nattanan Losuwannarak; Sittiruk Roytrakul; Pithi Chanvorachote
Journal:  Cancer Genomics Proteomics       Date:  2020 Nov-Dec       Impact factor: 4.069

8.  5-demethyltangeretin inhibits human nonsmall cell lung cancer cell growth by inducing G2/M cell cycle arrest and apoptosis.

Authors:  Noppawat Charoensinphon; Peiju Qiu; Ping Dong; Jinkai Zheng; Pearline Ngauv; Yong Cao; Shiming Li; Chi-Tang Ho; Hang Xiao
Journal:  Mol Nutr Food Res       Date:  2013-08-08       Impact factor: 5.914

9.  HNRNP A1 Promotes Lung Cancer Cell Proliferation by Modulating VRK1 Translation.

Authors:  Hye Guk Ryu; Youngseob Jung; Namgyu Lee; Ji-Young Seo; Sung Wook Kim; Kyung-Ha Lee; Do-Yeon Kim; Kyong-Tai Kim
Journal:  Int J Mol Sci       Date:  2021-05-23       Impact factor: 5.923

10.  Genome-Wide Analysis of Sex Disparities in the Genetic Architecture of Lung and Colorectal Cancers.

Authors:  Alireza Nazarian; Alexander M Kulminski
Journal:  Genes (Basel)       Date:  2021-05-01       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.